Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Glucagon response to oral glucose challenge in type 1 diabetes: lack of impact of euglycemia.

Kramer CK, Borgoño CA, Van Nostrand P, Retnakaran R, Zinman B.

Diabetes Care. 2014 Apr;37(4):1076-82. doi: 10.2337/dc13-2339. Epub 2013 Nov 15.

PMID:
24241790
2.

Response to comment on Kramer et al. Glucagon response to oral glucose challenge in type 1 diabetes: lack of impact of euglycemia. Diabetes Care 2014;37:1076-1082.

Kramer CK, Retnakaran R, Zinman B.

Diabetes Care. 2014 Oct;37(10):e225. doi: 10.2337/dc14-1636. No abstract available.

PMID:
25249685
3.

Response to comment on Kramer et al. Glucagon response to oral glucose challenge in type 1 diabetes: lack of impact of euglycemia. Diabetes Care 2014;37:1076-1082.

Kramer CK, Retnakaran R, Zinman B.

Diabetes Care. 2014 Sep;37(9):e209. doi: 10.2337/dc14-1392. No abstract available.

PMID:
25147269
4.

Comment on Kramer et al. Glucagon response to oral glucose challenge in type 1 diabetes: lack of impact of euglycemia. Diabetes Care 2014;37:1076-1082.

Takahashi N, Tsujimoto T, Kajio H.

Diabetes Care. 2014 Oct;37(10):e224. doi: 10.2337/dc14-1500. No abstract available.

PMID:
25249684
5.

Comment on Kramer et al. Glucagon response to oral glucose challenge in type 1 diabetes: lack of impact of euglycemia. Diabetes Care 2014;37:1076-1082.

Ali S, Kuhadiya N, Ghanim H, Chaudhuri A.

Diabetes Care. 2014 Sep;37(9):e208. doi: 10.2337/dc14-1271. No abstract available.

PMID:
25147268
6.

Inappropriate glucagon response after oral compared with isoglycemic intravenous glucose administration in patients with type 1 diabetes.

Hare KJ, Vilsbøll T, Holst JJ, Knop FK.

Am J Physiol Endocrinol Metab. 2010 Apr;298(4):E832-7. doi: 10.1152/ajpendo.00700.2009. Epub 2010 Jan 26.

7.

Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects.

Knop FK, Konings E, Timmers S, Schrauwen P, Holst JJ, Blaak EE.

Diabet Med. 2013 Oct;30(10):1214-8. doi: 10.1111/dme.12231. Epub 2013 Jun 7.

PMID:
23663119
8.

Impact of incretin on early-phase insulin secretion and glucose excursion.

Shen J, Chen Z, Chen C, Zhu X, Han Y.

Endocrine. 2013 Oct;44(2):403-10. doi: 10.1007/s12020-012-9867-9. Epub 2013 Jan 3.

PMID:
23283820
9.

The incretin effect in Korean subjects with normal glucose tolerance or type 2 diabetes.

Oh TJ, Kim MY, Shin JY, Lee JC, Kim S, Park KS, Cho YM.

Clin Endocrinol (Oxf). 2014 Feb;80(2):221-7. doi: 10.1111/cen.12167. Epub 2013 May 20.

PMID:
23405851
10.

Postprandial glucose, insulin and incretin responses to different carbohydrate tolerance tests.

Deng Y, Zhang Y, Zheng S, Hong J, Wang C, Liu T, Sun Z, Gu W, Gu Y, Shi J, Yao S, Wang W, Ning G.

J Diabetes. 2015 Nov;7(6):820-9. doi: 10.1111/1753-0407.12245. Epub 2015 Mar 4.

PMID:
25395350
11.

Postprandial responses of incretin and pancreatic hormones in non-diabetic patients with end-stage renal disease.

Idorn T, Knop FK, Jørgensen M, Holst JJ, Hornum M, Feldt-Rasmussen B.

Nephrol Dial Transplant. 2014 Jan;29(1):119-27. doi: 10.1093/ndt/gft353. Epub 2013 Sep 26.

PMID:
24078334
12.

Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.

Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, Nanjo K, Sasaki A, Seino Y, Ito C, Shima K, Nonaka K, Kadowaki T; Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus..

Diabetes Res Clin Pract. 2002 Jan;55(1):65-85.

PMID:
11755481
13.

Reduced postprandial GLP-1 responses in women with gestational diabetes mellitus.

Bonde L, Vilsbøll T, Nielsen T, Bagger JI, Svare JA, Holst JJ, Larsen S, Knop FK.

Diabetes Obes Metab. 2013 Aug;15(8):713-20. doi: 10.1111/dom.12082. Epub 2013 Mar 12.

PMID:
23406269
14.

The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes.

Lund A, Vilsbøll T, Bagger JI, Holst JJ, Knop FK.

Am J Physiol Endocrinol Metab. 2011 Jun;300(6):E1038-46. doi: 10.1152/ajpendo.00665.2010. Epub 2011 Mar 8.

16.
17.

Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus.

Cypryk K, Vilsbøll T, Nadel I, Smyczyńska J, Holst JJ, Lewiński A.

Gynecol Endocrinol. 2007 Jan;23(1):58-62.

PMID:
17484514
18.

Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.

Rask E, Olsson T, Söderberg S, Holst Jj Jj, Tura A, Pacini G, Ahrén B.

Metabolism. 2004 May;53(5):624-31.

PMID:
15131768
19.

Fasting and oral glucose-stimulated levels of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are highly familial traits.

Gjesing AP, Ekstrøm CT, Eiberg H, Urhammer SA, Holst JJ, Pedersen O, Hansen T.

Diabetologia. 2012 May;55(5):1338-45. doi: 10.1007/s00125-012-2484-6. Epub 2012 Feb 15.

PMID:
22349073
20.

Glucose-induced incretin hormone release and insulin sensitivity are impaired in patients with idiopathic gastroparesis: results from a pilot descriptive study.

Prévost G, Ducrotté P, Cailleux A, Khalfi K, Basuyau JP, Lefebvre H, Kuhn JM.

Neurogastroenterol Motil. 2013 Aug;25(8):694-9. doi: 10.1111/nmo.12150. Epub 2013 May 12.

Supplemental Content

Support Center